Evidence map›Paper›PMID 21417692›Full record

ArticleTissue engineering. Part A2011

Evaluating smooth muscle cells from CaCl2-induced rat aortal expansions as a surrogate culture model for study of elastogenic induction of human aneurysmal cells.

Carmen Gacchina, Thomas Brothers, Anand Ramamurthi

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Advances in biomimetic regeneration of elastic matrix structures.Drug delivery and translational research · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Carmen GacchinaClinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Thomas Brothers
Anand Ramamurthi
Clemson University · USMedical University of South Carolina · USNational Institutes of Health Clinical Center · US

Funding

TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR018823 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2003 to 2003
$2.9M
Hyaluronan Scaffold for Regenerating Elastin MatricesR21EB006078 · NIBIB · CLEMSON UNIVERSITY · PI RAMAMURTHI, ANAND · 2007 to 2008
$297k
NCRR NIH HHS C06RR018823NHLBI NIH HHS R01HL0092051-01A1NHLBI NIH HHS R01HL0092051-01SNHLBI NIH HHS T32 HL007260NIBIB NIH HHS R21EB006078-01A1
6 · The paper itself

Abstract

Regression of abdominal aortic aneurysms (AAAs) via regeneration of new elastic matrix is constrained by poor elastin synthesis by adult vascular cells and absence of methods to stimulate the same. We recently showed hyaluronan oligomers (HA-o) and TGF-β1 (termed elastogenic factors) to enhance elastin synthesis and matrix formation by healthy rat aortic smooth muscle cells (RASMCs). We also determined that these factors could likewise elastogenically induce aneurysmal RASMCs isolated from periadventitial CaCl(2)-injury induced rat AAAs (aRASMCs). However, the factor doses should be increased for these diseased cell types, as even when induced, elastic matrix amounts are roughly one order of magnitude lower than those produced by healthy RASMCs. We presently investigate the dose-specific elastogenic effects of HA-o (0-20  μg/mL) and TGF-β1 (0-10  ng/mL) factors on aRASMCs and compare their phenotype and elastogenic responses to those of human AAA-derived SMCs (aHASMCs); we seek to determine whether aRASMCs are appropriate surrogate cell types to study in the context of inducing elastic matrix regeneration within human AAAs. The periadventitial CaCl(2)-injury model of AAAs exhibits many of the pathological characteristics of human AAAs, including similarities in terms of decreased SMC contractile activity, enhanced proliferation, and reduced elastogenic capacity of aneurysmal SMCs (relative to healthy SMCs) when isolated and expanded in culture. Both aRASMCs and aHASMCs can be elastogenically stimulated by HA-o and TGF-β1 and show broadly similar trends in their dose-specific responses to these factors. However, compared with aHASMCs, aRASMCs appear to be far less elastogenically inducible. This may be due to differences in maturity of the AAAs studied, with the CaCl(2)-injury induced aortal expansion barely qualifying as an aneurysm and the human AAA representing a more well-developed condition. Further study of SMCs from stage-matched CaCl(2)-injury induced rat aortal expansions and human AAAs will be necessary to more rigorously evaluate their basal and induced elastogenic responses.

Indexed as

Models, BiologicalAnimalsAortaAortic Aneurysm, AbdominalBiomarkersCalcium ChlorideCell ProliferationCells, CulturedDisease ProgressionElastinExtracellular MatrixFluorescent Antibody TechniqueHumansHyaluronic AcidMaleMiddle AgedBiomarkersCalcium ChlorideElastinHyaluronic AcidTransforming Growth Factor beta1

Identifiers

PMID21417692
PMCPMC3142653
OpenAlexW1985922835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.